Johnson County Clin Trials

Randomized Adaptive Study for Safety and Efficacy of IMM01-STEM on Muscle Performance in Seniors with Sarcopenic Obesity.

A Phase 2b, Double-Blind, Multi-Center, Randomized, Comparator-Controlled Trial to Determine the Relative Efficacy, Safety, And Immunogenicity of he Investigational Oral SARS-COV-2 Vaccine Tablet (VXA-COV2-3.1) Against Currently Approved/Authorized MRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection

A Phase 3, Randomized, Observer-blinded, Placebo-controlled Study to Evaluate the Safety and Efficacy of mRNA-1403, a Multivalent Candidate Vaccine to Prevent Norovirus Acute Gastroenteritis in Adults ≥18 Years of Age

A Phase 1, single center, open label, single dose, dose escalation study to determine the safety and immunogenicity of a novel bivalent norovirus G1.1 and G2.4 vaccine administered orally to healthy volunteers aged ≥18 years and ≤80 years old.

A two-stage, randomized, double-blind, dose ranging phase 2 trial in healthy adult participants to investigate optimal dose and dosing regimen, and to evaluate safety and immunogenicity of the recombinant MVA‑BN‑WEV vaccine.

A Phase 2, Randomized, Observer-blind Study to Evaluate the Safety, Reactogenicity, and Immunogenicity in Relation to the Product Attributes of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Adults ≥50 to <65 Years of Age